Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Oates, Jim

One or more keywords matched the following properties of Oates, Jim

Property	Value
overview	Dr. Jim Oates is a professor and Associate Director in the Division of Rheumatology and Immunology at the Medical University of South Carolina. He received a BS in chemistry at Bates College and a medical degree from Johns Hopkins School of Medicine in 1991. He completed his internship and residency in internal medicine and fellowship in rheumatology at Duke University Medical Center in 1996. He came to the Medical University of South Carolina in 1996 to complete a research fellowship and joined the faculty of the Division of Rheumatology in 1997. He became Chief of the Rheumatology Service at the Ralph H Johnson VA Medical Center in 2007, the Informatics Medical Director of Research and Reporting in 2013, and Vice Chair for Research in the Department of Medicine in 2016. Dr. Oates' clinical and research interests are focused on systemic lupus erythematosus. He is involved in clinical trials of therapies for systemic lupus erythematosus and lupus nephritis and is the principal investigator on several studies at MUSC involving noninvasive markers of disease and mechanisms through which disease severity may increase among African-Americans. Dr. Oates is an active member of the M.U.S.C.L.E. Research Group. His translational work is focused on the role of reactive intermediates and oxidative stress in the endothelial dysfunction that leads to atherosclerosis and renal disease in patients with lupus. He is also studying machine learning biomarker models of outcome in lupus nephritis. He has supported clinical research at a regional and national level by serving as the President American Federation for Medical Research and the President of the Southern Society for Clinical Investigation, where he also serves as an Associate Editor of its journal, the American Journal of Medical Sciences. He has received numerous awards, including Phi Beta Kappa from Bates College, the Four Schools Physician Scientist Training Program Scholarship from the Johns Hopkins School of Medicine, the Senior Rheumatology Scholar Award from the American College of Rheumatology (ACR), the Arthritis Investigator Award from the ACR and its foundation, the Research Education Foundation (REF), the Merck Young Investigator Award, the REF/European League Against Rheumatism International Exchange Award, and the Developing Scholar Award from the Medical University of South Carolina Health Sciences Foundation.
overview	Dr. Jim Oates is Professor and Director in the Division of Rheumatology and Immunology and Vice Chair for Research in the Department of Medicine at the Medical University of South Carolina. He received a BS in chemistry at Bates College and a medical degree from Johns Hopkins School of Medicine in 1991. He completed his internship and residency in internal medicine and fellowship in rheumatology at Duke University Medical Center in 1996. He came to the Medical University of South Carolina in 1996 to complete a research fellowship and joined the faculty of the Division of Rheumatology in 1997. He became Chief of the Rheumatology Service at the Ralph H Johnson VA Medical Center in 2007, the Informatics Medical Director of Research and Reporting in 2013, and Vice Chair for Research in the Department of Medicine in 2016. Dr. Oates' clinical and research interests are focused on systemic lupus erythematosus. He is involved in clinical trials of therapies for systemic lupus erythematosus and lupus nephritis and is the principal investigator on several studies at MUSC involving noninvasive markers of disease and mechanisms through which disease severity may increase among African-Americans. Dr. Oates is an active member of the M.U.S.C.L.E. Research Group. His translational work is focused on the role of reactive intermediates and oxidative stress in the endothelial dysfunction that leads to atherosclerosis and renal disease in patients with lupus. He is also studying machine learning biomarker models of outcome in lupus nephritis. He has supported clinical research at a regional and national level by serving as the President American Federation for Medical Research and the President of the Southern Society for Clinical Investigation, where he also serves as an Associate Editor of its journal, the American Journal of Medical Sciences. He has received numerous awards, including Phi Beta Kappa from Bates College, the Four Schools Physician Scientist Training Program Scholarship from the Johns Hopkins School of Medicine, the Senior Rheumatology Scholar Award from the American College of Rheumatology (ACR), the Arthritis Investigator Award from the ACR and its foundation, the Research Education Foundation (REF), the Merck Young Investigator Award, the REF/European League Against Rheumatism International Exchange Award, and the Developing Scholar Award from the Medical University of South Carolina Health Sciences Foundation.

Property

Value

overview

Dr. Jim Oates is a professor and Associate Director in the Division of Rheumatology and Immunology at the Medical University of South Carolina. He received a BS in chemistry at Bates College and a medical degree from Johns Hopkins School of Medicine in 1991. He completed his internship and residency in internal medicine and fellowship in rheumatology at Duke University Medical Center in 1996. He came to the Medical University of South Carolina in 1996 to complete a research fellowship and joined the faculty of the Division of Rheumatology in 1997. He became Chief of the Rheumatology Service at the Ralph H Johnson VA Medical Center in 2007, the Informatics Medical Director of Research and Reporting in 2013, and Vice Chair for Research in the Department of Medicine in 2016. Dr. Oates' clinical and research interests are focused on systemic lupus erythematosus. He is involved in clinical trials of therapies for systemic lupus erythematosus and lupus nephritis and is the principal investigator on several studies at MUSC involving noninvasive markers of disease and mechanisms through which disease severity may increase among African-Americans. Dr. Oates is an active member of the M.U.S.C.L.E. Research Group. His translational work is focused on the role of reactive intermediates and oxidative stress in the endothelial dysfunction that leads to atherosclerosis and renal disease in patients with lupus. He is also studying machine learning biomarker models of outcome in lupus nephritis. He has supported clinical research at a regional and national level by serving as the President American Federation for Medical Research and the President of the Southern Society for Clinical Investigation, where he also serves as an Associate Editor of its journal, the American Journal of Medical Sciences. He has received numerous awards, including Phi Beta Kappa from Bates College, the Four Schools Physician Scientist Training Program Scholarship from the Johns Hopkins School of Medicine, the Senior Rheumatology Scholar Award from the American College of Rheumatology (ACR), the Arthritis Investigator Award from the ACR and its foundation, the Research Education Foundation (REF), the Merck Young Investigator Award, the REF/European League Against Rheumatism International Exchange Award, and the Developing Scholar Award from the Medical University of South Carolina Health Sciences Foundation.

overview

Dr. Jim Oates is Professor and Director in the Division of Rheumatology and Immunology and Vice Chair for Research in the Department of Medicine at the Medical University of South Carolina. He received a BS in chemistry at Bates College and a medical degree from Johns Hopkins School of Medicine in 1991. He completed his internship and residency in internal medicine and fellowship in rheumatology at Duke University Medical Center in 1996. He came to the Medical University of South Carolina in 1996 to complete a research fellowship and joined the faculty of the Division of Rheumatology in 1997. He became Chief of the Rheumatology Service at the Ralph H Johnson VA Medical Center in 2007, the Informatics Medical Director of Research and Reporting in 2013, and Vice Chair for Research in the Department of Medicine in 2016. Dr. Oates' clinical and research interests are focused on systemic lupus erythematosus. He is involved in clinical trials of therapies for systemic lupus erythematosus and lupus nephritis and is the principal investigator on several studies at MUSC involving noninvasive markers of disease and mechanisms through which disease severity may increase among African-Americans. Dr. Oates is an active member of the M.U.S.C.L.E. Research Group. His translational work is focused on the role of reactive intermediates and oxidative stress in the endothelial dysfunction that leads to atherosclerosis and renal disease in patients with lupus. He is also studying machine learning biomarker models of outcome in lupus nephritis. He has supported clinical research at a regional and national level by serving as the President American Federation for Medical Research and the President of the Southern Society for Clinical Investigation, where he also serves as an Associate Editor of its journal, the American Journal of Medical Sciences. He has received numerous awards, including Phi Beta Kappa from Bates College, the Four Schools Physician Scientist Training Program Scholarship from the Johns Hopkins School of Medicine, the Senior Rheumatology Scholar Award from the American College of Rheumatology (ACR), the Arthritis Investigator Award from the ACR and its foundation, the Research Education Foundation (REF), the Merck Young Investigator Award, the REF/European League Against Rheumatism International Exchange Award, and the Developing Scholar Award from the Medical University of South Carolina Health Sciences Foundation.

One or more keywords matched the following items that are connected to Oates, Jim

Item Type	Name
Academic Article	Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Concept	Quality of Life
Concept	Half-Life
Academic Article	An Intervention to Reduce Psychosocial and Biological Indicators of Stress in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies Study.
Academic Article	Stress Intervention and Disease in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies (BLESS) Study.
Academic Article	Co-inheritance of the polymorphic metabolism of encainide and debrisoquin.
Academic Article	Predictors of non-response and non-compliance in African American lupus patients: Findings from the Balancing Lupus Experiences with Stress Strategies (BLESS) Study.
Academic Article	Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans.
Academic Article	Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-Management (PALS) project.
Grant	MCRC for Rheumatic Diseases in African Americans
Academic Article	My life with lupus: contextual responses of African-American women with systemic lupus participating in a peer mentoring intervention to improve disease self-management.
Academic Article	Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study.
Academic Article	Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial.
Concept	Th1-Th2 Balance

Search Criteria

Work
Life
Balance